Dimerix doubles as biotech lands licensing deal for kidney treatment
MELBOURNE: Dimerix shares more than doubled on Thursday after the biotechnology company announced ...
To read the full story...SUBSCRIBE NOWExisting Subscribers Login Below:
Log In
